Christopher Viehbacher is President and Chief Executive Officer of Biogen Inc. (BIIB). The company reported total compensation of $23,646,004 for fiscal year 2025.
| Salary | $1,727,885 |
|---|---|
| Bonus | $0 |
| Stock awards | $18,368,875 |
| Option awards | $0 |
| Non-equity incentive plan | $3,190,875 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $358,369 |
| Total | $23,646,004 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Biogen Inc. filed April 28, 2026, accession 0001193125-26-187303.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President and Chief Executive Officer | $1,727,885 | $0 | $18,368,875 | $0 | $3,190,875 | $0 | $358,369 | $23,646,004 |
| FY2024 | President and Chief Executive Officer | $1,600,000 | — | $18,010,911 | — | $4,308,480 | $3,573 | $243,701 | $24,166,665 |
| FY2023 | President and Chief Executive Officer | $1,600,000 | — | $0 | — | $2,376,000 | $39 | $93,874 | $4,069,913 |
| FY2022 | President and Chief Executive Officer | $153,846 | $0 | $18,800,045 | $11,200,610 | $315,616 | $0 | $18,476 | $30,488,593 |
Totals as disclosed in each year's own compensation disclosure for Biogen Inc..
| Peer-group chief executive median | $21,144,261 |
|---|---|
| Difference from that median | $2,501,743 |
| Percentile within the disclosed peer group | 67th |
| Peers with a disclosed figure | 15 |
Medians and percentiles are computed across the peer group Biogen Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Christopher Viehbacher this page | President and Chief Executive Officer | $23,646,004 |
| Susan Alexander | Executive Vice President, Chief Legal Officer | $8,132,517 |
| Nicole Murphy | Head of Pharmaceutical Operations and Technology | $7,575,505 |
| Priya Singhal | Head of Development | $7,571,387 |
| Robin Kramer | Executive Vice President and Chief Financial Officer | $5,806,584 |
| Michael McDonnell | Former Executive Vice President and Chief Financial Officer | $270,850 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Biogen Inc. compensation brief.
Christopher Viehbacher's compensation sits inside Biogen Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.